Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-12-001259
Filing Date
2012-03-22
Accepted
2012-03-22 17:13:34
Documents
2
Group Members
KEVIN C. TANGTANG CAPITAL MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 s321121sc13g.htm SC 13G 125615
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 14162
  Complete submission text file 0001214659-12-001259.txt   141445
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 12709885
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

EIN.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G